Cargando…
Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine
Vaccine efficacy of conventional influenza vaccines depend on the antigenic similarity between the selected vaccine strain and annual epidemic strain. Since the influenza virus evolves yearly, a vaccine which is independent from viral antigenic mutation is desired. We have developed chimeric cytokin...
Autores principales: | Imagawa, Toshifumi, Arasaki, Youta, Maegawa, Kenichi, Sugita, Shigeo, Nerome, Kuniaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224270/ https://www.ncbi.nlm.nih.gov/pubmed/37237374 http://dx.doi.org/10.1186/s12985-023-02076-1 |
Ejemplares similares
-
The potential of a universal influenza virus-like particle vaccine expressing a chimeric cytokine
por: Nerome, Kuniaki, et al.
Publicado: (2022) -
Interleukin 12-containing influenza virus-like-particle vaccine elevate its protective activity against heterotypic influenza virus infection
por: Maegawa, Kenichi, et al.
Publicado: (2020) -
Development of a Japanese encephalitis virus-like particle vaccine in silkworms using codon-optimised prM and envelope genes
por: Matsuda, Sayaka, et al.
Publicado: (2017) -
Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia azedarach L.
por: Nerome, Kuniaki, et al.
Publicado: (2018) -
Chimeric Virus-like Particles Co-Displaying Hemagglutinin Stem and the C-Terminal Fragment of DnaK Confer Heterologous Influenza Protection in Mice
por: Liu, Cui-Cui, et al.
Publicado: (2022)